Overview

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The objective of PHAGOBURN is to assess tolerance and efficacy of local bacteriophage treatment of E. coli or P. aeruginosa wound infections in burned patients.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Pherecydes Pharma

Treatments:

Silver Sulfadiazine
Sulfadiazine